Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Heart Failure
Condition(s):Heart FailureLast Updated:November 30, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Heart FailureLast Updated:November 30, 2017Completed
Condition(s):Quality of LifeLast Updated:December 4, 2014Completed
Condition(s):ViolenceLast Updated:January 5, 2021Completed
Condition(s):Pancreatic Adenocarcinoma ResectableLast Updated:May 6, 2021Withdrawn
Condition(s):Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Myelodysplastic Syndromes; Non-Hodgkin Lymphoma; Hodgkin DiseaseLast Updated:March 12, 2024Active, not recruiting
Condition(s):GastroIntestinal Bleeding; Anticoagulant-induced BleedingLast Updated:November 3, 2023Recruiting
Condition(s):Cardiovascular Diseases; Infant ALL; Maternal Behavior; Childhood ObesityLast Updated:November 15, 2023Recruiting
Condition(s):Hepatocellular CancerLast Updated:August 18, 2022Completed
Condition(s):Major Depressive Disorder; NeoplasmsLast Updated:March 13, 2017Completed
Condition(s):Absence; School Phobia; Truancy; Socialized; Depression, AnxietyLast Updated:December 12, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.